Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients. | Front Genet | 2022 | 36186456 | PubTator, text mining | PubMed |
| 4-1BB: A promising target for cancer immunotherapy. | Front Oncol | 2022 | 36185242 | PubTator, text mining | PubMed |
| FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration. | Front Oncol | 2022 | 36185230 | PubTator, text mining | PubMed |
| Overcoming the cardiac toxicities of cancer therapy immune checkpoint inhibitors. | Front Oncol | 2022 | 36185227 | PubTator, text mining | PubMed |
| Crosstalk between dendritic cells and regulatory T cells: Protective effect and therapeutic potential in multiple sclerosis. | Front Immunol | 2022 | 36177043 | PubTator, text mining | PubMed |
| CD1d-independent NK1.1+ Treg cells are IL2-inducible Foxp3+ T cells co-expressing immunosuppressive and cytotoxic molecules. | Front Immunol | 2022 | 36177042 | PubTator, text mining | PubMed |
| Development and characterization of a novel human CD137 agonistic antibody with anti-tumor activity and a good safety profile in non-human primates. | FEBS Open Bio | 2022 | 36176235 | PubTator, text mining | PubMed |
| Single-cell analysis of immune cell transcriptome during HIV-1 infection and therapy. | BMC Immunol | 2022 | 36175869 | PubTator, text mining | PubMed |
| Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential. | Cell Mol Life Sci | 2022 | 36173485 | PubTator, text mining | PubMed |
| Autologous blood extracellular vesicles and specific CD4+ T-cell co-activation. | Front Immunol | 2022 | 36172364 | PubTator, text mining | PubMed |
| Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy. | J Immunother Cancer | 2022 | 36171009 | PubTator, text mining | PubMed |
| Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy. | Theranostics | 2022 | 36168626 | PubTator, text mining | PubMed |
| TRAF3 enhances type I interferon receptor signaling in T cells by modulating the phosphatase PTPN22. | Sci Signal | 2022 | 36166512 | PubTator, text mining | PubMed |
| CPHEN-016: Comprehensive phenotyping of human regulatory T cells. | Cytometry A | 2022 | 36165514 | PubTator, text mining | PubMed |
| Histone methylation modification patterns and relevant M-RiskScore in acute myeloid leukemia. | Heliyon | 2022 | 36164519 | PubTator, text mining | PubMed |
| Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo. | J Immunol Res | 2022 | 36164321 | PubTator, text mining | PubMed |
| An acetonic extract and secondary metabolites from the endolichenic fungus Nemania sp. EL006872 exhibit immune checkpoint inhibitory activity in lung cancer cell. | Front Pharmacol | 2022 | 36160406 | PubTator, text mining | PubMed |
| MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma. | Front Genet | 2022 | 36159990 | PubTator, text mining | PubMed |
| Tipping the scales: Immunotherapeutic strategies that disrupt immunosuppression and promote immune activation. | Front Immunol | 2022 | 36159809 | PubTator, text mining | PubMed |
| Identification of key genes and mechanisms of epicardial adipose tissue in patients with diabetes through bioinformatic analysis. | Front Cardiovasc Med | 2022 | 36158806 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=48